Precision neurology is transforming the
Neuroscience Market through biomarker-driven patient stratification and targeted therapies. Genetic profiling guides treatment selection for epilepsy, migraine, and psychiatric conditions. Digital biomarkers from smartphones and wearables enable continuous, objective neurological monitoring.
The
Neuroscience Market anticipates converging technologies including AI-guided drug discovery, neurostimulation-drug combinations, and regenerative approaches. Stem cell therapies for Parkinson's and spinal cord injury advance through clinical trials. Neuroplasticity-enhancing interventions may enable functional recovery beyond traditional neuroprotection.
FAQ
Q: What is precision neurology? A: Using genetic, biomarker, and imaging data to tailor neurological treatments to individual patient characteristics.
Q: How do digital biomarkers help? A: Continuous monitoring of gait, speech, sleep, and cognition enables early detection and treatment response assessment.
Q: What regenerative approaches are emerging? A: iPSC-derived dopaminergic neurons, neural stem cell transplants, and gene therapy-mediated neurotrophic factor delivery.
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek
Bengali